Vyjuvek
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Vyjuvek, covering 2025-02-28 to 2026-06-08. Get the full timeline:
Most recent: EMA Authorised: Vyjuvek (Beremagene geperpavec) — Krystal Biotech Netherlands B.V.